The regulatory relationship between UCP2 and ROS-related pathways not only influences pancreatic endocrine diseases by affecting the insulin secretory function of β-cells but also contributes to the progression of AP and PDAC. This evidence concerns the gene UCP2 and alkaline phosphatase measurement.